SAN DIEGO, CA--(Marketwire - November 09, 2007) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced its financial results for the third quarter of 2007. For the quarter ended September 30, 2007, the Company reported a net loss of approximately $1.1 million or $0.03 per share basic and diluted compared to a net loss of approximately $1.4 million or $0.04 per share basic and diluted for the corresponding period in 2006. At September 30, 2007, the Company had cash, cash equivalents and investments totaling $177.3 million.
